$IVZ

Invesco Ltd.

4
4
1

No SEC Form 4 filings for $IVZ in the last 30 days.

Med

Invesco shareholders approve board nominees and bylaw amendment at annual meeting

Invesco Ltd. shareholders approved all eleven board nominees, executive compensation, and the appointment of PricewaterhouseCoopers LLP as the independent auditor during their recent Annual General Meeting. Additionally, an amendment to the company's bylaws was approved, allowing shareholders to remove a director with or without cause. This positive outcome follows a strong first quarter for Invesco in 2026, where revenue surpassed forecasts and assets under management increased significantly.

[424B2] BARCLAYS BANK PLC Prospectus Supplement

Barclays Bank PLC is offering structured Notes due May 24, 2029, linked to the performance of the iShares Russell 2000 ETF (IWM), Invesco QQQ Trust Series 1 (QQQ), and State Street SPDR S&P 500 ETF Trust (SPY). These Notes offer a contingent coupon of $21.00 per $1,000 on observation dates if each underlier closes at or above its coupon barrier, with potential for early automatic redemption. Investors face principal loss risk tied to the least performing underlier and are exposed to Barclays' credit risk and U.K. bail-in powers.

Invesco Ltd. stock (BMG491BT1088): Q1 earnings lift shares and capital return plans draw focus

Invesco Ltd. shares rose after the asset manager reported stronger first-quarter 2026 results and announced plans for higher capital returns, bringing its global investment platform into focus for US investors. The company's business model, which includes ETFs, active strategies, and institutional mandates, relies on market performance and investor flows. For US investors, Invesco provides exposure to the asset management sector, with both opportunities from asset growth and risks associated with market volatility and regulatory changes.